The Role of Liver Fibrosis Assessment in the Management of Patients with Chronic Hepatitis B Infection: Lessons Learned from a Single Centre Experience
Hepatitis Research and Treatment · 2011
DOI: 10.1155/2011/524027 ↗Kurz gefasst
Fachartikel in der Zeitschrift Hepatitis Research and Treatment, 2011. Verfasst von Raza Malik und 7 weiteren Autor:innen. Beteiligte Einrichtung: Liver Center, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, 110 Francis Street, Suite 4A, Boston, MA 02215, U…. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).
Abstract (Originalsprache)
Background & Aims . Assess the clinical utility of the Prati criteria and normal ALT ( 6 log copies/ml and normal ALT, who in fact had moderate/severe fibrosis on liver biopsy. HBeAg − group: 10 patients with normal ALT and moderate/severe fibrosis on liver biopsy; 4 of these patients had >3 log copies/ml HBV DNA levels and 6 patients misclassified as “inactive carriers” with negative HBV DNA levels normal ALT and moderate/severe fibrosis (6/84−7% HBeAg − group). Two male HBeAg + and three male HBeAg - patients with ALT between 20 and 30 IU/L and moderate/severe fibrosis on liver biopsy would have been further mischaracterised using the Prati criteria for normal ALT. Age and ethnic group were more important predictors of moderate/severe fibrosis in multivariate analysis. Conclusion . HBeAg status, age, ethnic origin with longitudinal assessment of LFTs and viral load should be studied in patients with “normal ALT” at the upper end of normal range (ALT 20–40 IU/L) to appropriately classify patients and identify patients for liver fibrosis assessment to inform treatment decisions.
Autor:innen und Institutionen
- Liver Center, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, 110 Francis Street, Suite 4A, Boston, MA 02215, USA.
Zitieren
APA
Malik, R., Kennedy, P., Suri, D., Brown, A., Goldin, R., Main, J., Thomas, H., & Thursz, M. (2011). The Role of Liver Fibrosis Assessment in the Management of Patients with Chronic Hepatitis B Infection: Lessons Learned from a Single Centre Experience. Hepatitis Research and Treatment. https://doi.org/10.1155/2011/524027
Vancouver
Malik R, Kennedy P, Suri D, Brown A, Goldin R, Main J, et al. The Role of Liver Fibrosis Assessment in the Management of Patients with Chronic Hepatitis B Infection: Lessons Learned from a Single Centre Experience. Hepatitis Research and Treatment. 2011. doi:10.1155/2011/524027
BibTeX
@article{Malik2011,
author = {Malik, Raza and Kennedy, Patrick and Suri, Deepak and Brown, Ashley and Goldin, Rob and Main, Janice and Thomas, Howard and Thursz, Mark},
title = {The Role of Liver Fibrosis Assessment in the Management of Patients with Chronic Hepatitis B Infection: Lessons Learned from a Single Centre Experience},
journal = {Hepatitis Research and Treatment},
year = {2011},
doi = {10.1155/2011/524027}
}
EUVIMED